Breast cancer onset in twins and women with bilateral disease

Journal of Clinical Oncology

Volumn 26, Issue 25, 2008, Pages 4086-4091

  Hartman, Mikael ^a   Hall, Per ^a   Edgren, Gustaf ^a   Reilly, Marie ^a   Lindstrom, Linda ^a   Lichtenstein, Paul ^a   Kaprio, Jaakko ^a   Skytthe, Axel ^a   Peto, Julian ^a   Czene, Kamila ^a  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIZYGOTIC TWINS; FAMILY HISTORY; FEMALE; GENETICS; HIGH RISK POPULATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MONOZYGOTIC TWINS; PRIORITY JOURNAL; RISK ASSESSMENT; TWINS;

BREAST NEOPLASMS; COHORT STUDIES; DENMARK; DISEASES IN TWINS; FAMILY HEALTH; FEMALE; FINLAND; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; ODDS RATIO; RISK; SWEDEN; TIME FACTORS; TREATMENT OUTCOME;

EID: 51649120857     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.14.3198     Document Type: Article

References (41)

1. Familial breast cancer: Collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 358:1389-1399, 2001
2. Lichtenstein P, Holm NV, Verkasalo PK, et al: Environmental and heritable factors in the causation of cancer: Analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78-85, 2000
3. Czene K, Lichtenstein P, Hemminki K: Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int J Cancer 99:260-266, 2002
4. Hartman M, Czene K, Reilly M, et al: Genetic implications of bilateral breast cancer: A population based cohort study. Lancet Oncol 6:377-382, 2005
5. Pharoah PD, Antoniou A, Bobrow M, et al: Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31:33-36, 2002
6. Easton DF, Pooley KA, Dunning AM, et al: Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447:1087-1093, 2007
7. Chen Y, Thompson W, Semenciw R, et al: Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev 8:855-861, 1999
8. Peto J, Mack TM: High constant incidence in twins and other relatives of women with breast cancer. Nat Genet 26:411-414, 2000
9. Parkin DM, Bray F, Ferlay J, et al: Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153-156, 2001
10. Hemminki K, Li X, Czene K: Familial risk of cancer: Data for clinical counseling and cancer genetics. Int J Cancer 108:109-114, 2004
11. Cederlöf R, Lorich U: The Swedish Twin Registry. Prog Clin Biol Res 24:189-195, 1978
12. Skytthe A, Kyvik K, Holm NV, et al: The Danish Twin Registry: 127 birth cohorts of twins. Twin Res 5:352-357, 2002
13. Skytthe A, Kyvik K, Bathum L, et al: The Danish Twin Registry in the new millennium. Twin Res Hum Genet 9:763-771, 2006
14. Hauge M, Harvald B, Fischer M, et al: The Danish twin register. Acta Genet Med Gemellol (Roma) 17:315-332, 1968
15. Hauge M: The Danish Twin Register, in Mednick SA, Baert AE, Bachmann BP (eds): Prospective Longitudinal Research: An Empirical Basis for the Primary Prevention of Psychosocial Disorders. Oxford, United Kingdom, Oxford University Press, 1981, pp 217-221
16. Kyvik KO, Christensen K, Skytthe A, et al: The Danish Twin Register. Dan Med Bull 43:467-470, 1996
17. Kaprio J, Sarna S, Koskenvuo M, et al: The Finnish Twin Registry: Formation and compilation, questionnaire study, zygosity determination procedures, and research program. Prog Clin Biol Res 24 Pt B:179-184, 1978
18. Statistics Sweden: Cancer incidence in Sweden 2002. Stockholm, Sweden, Stat Health Diseases, 2003
19. Clemmesen J: Statistical Studies in the Aetiology of Malignant Neoplasms. I. Review and Results Supplement 174. I. Acta Pathol Microbiol Scand 54:1-543, 1965
20. Storm HH, Michelsen EV, Clemmensen IH, et al: The Danish Cancer Registry: History, content, quality and use. Dan Med Bull 44:535-539, 1997
21. Storm HH PJ, Michelsen EV, Nielsen AL: Cancer Incidence in Denmark 1993. Copenhagen, Denmark, Danish Cancer Society, 1996
22. Teppo L, Pukkala E, Lehtonen M: Data quality and quality control of a population-based cancer registry: Experience in Finland. Acta Oncol 33:365-369, 1994
23. Cederlof R, Friberg L, Jonsson E, et al: Studies on similarity diagnosis in twins with the aid of mailed questionnaires. Acta Genet Stat Med 11:338-362, 1961
24. Sarna S, Kaprio J, Sistonen P, et al: Diagnosis of twin zygosity by mailed questionnaire. Hum Hered 28:241-254, 1978
25. Hartman M, Czene K, Reilly M, et al: Incidence and prognosis of synchronous and metachronous bilateral breast cancer. J Clin Oncol 25:4210-4216, 2007
26. Clayton D HM: Statistical models in epidemiology. New York, NY, Oxford University Press, 1993
27. SAS Institute I: SAS/STAT user's guide, Version 8.2. Cary, NC, SAS Institute, 1999
28. Hemminki K, Li X, Plna K, et al: The nationwide Swedish Family-Cancer Database: Updated structure and familial rates. Acta Oncol 40:772-777, 2001
29. Lehman CD, Gatsonis C, Kuhl CK, et al: MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 356:1295-1303, 2007
30. Polychemotherapy for early breast cancer: An overview of the randomised trials - Early Breast Cancer Trialists' Collaborative Group. Lancet 352:930-942, 1998
31. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 365:1687-1717, 2005
32. Onkologiskt centrum Sll. http://www.sll.se/oc
33. Harvey EB, Brinton LA: Second cancer following cancer of the breast in Connecticut, 1935-82. Natl Cancer Inst Monogr 68:99-112, 1985
34. Antoniou AC, Pharoah PP, Smith P, et al: The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer 91:1580-1590, 2004
35. Ekbom A, Hsieh CC, Lipworth L, et al: Intrauterine environment and breast cancer risk in women: A population-based study. J Natl Cancer Inst 89:71-76, 1997
36. Breast cancer and breastfeeding: Collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 360:187-195, 2002
37. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer - Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 350:1047-1059, 1997
38. Michels KB, Mohllajee AP, Roset-Bahmanyar E, et al: Diet and breast cancer: A review of the prospective observational studies. Cancer 109:2712-2749, 2007
39. Einarsdóttir K, Humphreys K, Bonnard C, et al: Linkage disequilibrium mapping of CHEK2: Common variation and breast cancer risk. PLoS Med 3:e168, 2006
40. Tischkowitz M, Xia B, Sabbaghian N, et al: Analysis of PALB2/FANCN-associated breast cancer families. Proc Natl Acad Sci U S A 104:6788-6793, 2007
41. Weischer M, Bojesen SE, Ellervik C, et al: CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: Meta-analyses of 26,000 patient cases and 27,000 controls. J Clin Oncol 26:542-548, 2008